MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
54 hedge funds and large institutions have $37.9M invested in Merrimack Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 10 closing their positions.
Holders
54
Holders Change
-2
Holders Change %
-3.57%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
8
Increased
11
Reduced
17
Closed
10
Calls
$110K
Puts
$49K
Net Calls
+$61K
Net Calls Change
+$84K
Top Buyers
1 |
2L
1
22NW LP
Seattle,
Washington
|
$7.59M |
2 |
WSL
2
Western Standard LLC
Los Angeles,
California
|
$2.96M |
3 |
NM
3
Newtyn Management
New York
|
$7.96M |
4 |
4
Dimensional Fund Advisors
Austin,
Texas
|
$4.55M |
5 |
5
Invesco
Atlanta,
Georgia
|
$404K |